From: Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan
Variable | Total | Quartiles (mg/dL) | P value | |||
---|---|---|---|---|---|---|
Q1 (38–96) | Q2 (97–113) | Q3 (114–132) | Q4 (133–252) | |||
Women (n, %) | 2185 (52.9) | 537 (58.8) | 570 (53.8) | 547 (50.1) | 531 (49.9) | <.001 |
Age (years, %) | Â | Â | Â | Â | Â | <.001 |
 20–64 | 3590 (87.0) | 848 (92.9) | 947 (89.4) | 924 (84.6) | 871 (81.9) |  |
  ≥ 65 | 538 (13.0) | 65 (7.1) | 112 (10.6) | 168 (15.4) | 193 (18.1) |  |
BMI (kg/m2, %) | Â | Â | Â | Â | Â | <.001 |
  < 18.5 | 202 (5.7) | 81 (10.3) | 62 (6.8) | 39 (4.2) | 20 (2.2) |  |
 18.5–23.9 | 1916 (53.7) | 497 (63.2) | 531 (58.0) | 483 (51.5) | 405 (43.7) |  |
 24–26.9 | 917 (25.7) | 137 (17.4) | 219 (23.9) | 264 (28.1) | 297 (32.0) |  |
  ≥ 27 | 532 (14.9) | 71 (9.0) | 104 (11.4) | 152 (16.2) | 205 (22.1) |  |
Current smoker (n, %) | 822 (19.9) | 170 (18.6) | 219 (20.7) | 227 (20.8) | 206 (19.4) | 0.56 |
Alcohol drinking (n, %) | 985 (23.9) | 212 (23.2) | 269 (25.4) | 260 (23.8) | 244 (22.9) | 0.55 |
Betel nuts consumption (n, %) | 298 (7.2) | 72 (7.9) | 84 (7.9) | 74 (6.8) | 68 (6.4) | 0.42 |
Regular exercise (n, %) | 962 (23.3) | 204 (22.3) | 218 (20.6) | 287 (26.3) | 253 (23.8) | 0.015 |
Married (n, %) | 2569 (62.2) | 482 (52.8) | 619 (58.5) | 737 (67.5) | 731 (68.7) | <.001 |
Education level | Â | Â | Â | Â | Â | <.001 |
 Lower education (n, %) | 2143 (51.9) | 403 (44.1) | 495 (46.7) | 590 (54.0) | 655 (61.6) |  |
 Higher education (n, %) | 1985 (48.1) | 510 (55.9) | 564 (53.3) | 502 (46.0) | 409 (38.4) |  |
Low income level (n, %) | 2940 (71.2) | 674 (73.8) | 739 (69.8) | 760 (69.6) | 767 (72.1) | 0.12 |
Hypertension (n, %) | 237 (5.7) | 29 (3.2) | 39 (3.7) | 73 (6.7) | 96 (9.0) | <.001 |
Diabetes mellitus (n, %) | 192 (4.7) | 26 (2.9) | 31 (2.9) | 58 (5.3) | 77 (7.2) | <.001 |
hsCRP (mg/L) | 0.24 (0.55) | 0.17 (0.39) | 0.21 (0.47) | 0.27 (0.75) | 0.27 (0.48) | <.001 |
Menopause (n, %) | 771 (18.7) | 85 (9.3) | 157 (14.8) | 227 (20.8) | 302 (28.4) | <.001 |
Hormone replacement therapy (n, %) | 357 (8.7) | 80 (8.8) | 87 (8.2) | 94 (8.6) | 96 (9.0) | 0.93 |
Lipid-lowering agent use (n, %) | 624 (15.1) | 49 (5.4) | 92 (8.7) | 172 (15.8) | 311 (29.2) | <.001 |
Lipid profile (mg/dL) | ||||||
 TC (n = 4128) |  | 146.0 (20.1) | 171.7 (21.4) | 192.3 (16.6) | 230.0 (29.8) | <.001 |
 LDL-C (n = 4128) |  | 84.6 (9.1) | 105.0 (4.8) | 122.3 (5.3) | 153.1 (18.8) | <.001 |
 Triglycerides (n = 4099) |  | 94.6 (69.0) | 119.9 (83.3) | 137.8 (82.1) | 164.2 (92.5) | <.001 |
 Non-HDL-C (n = 4128) |  | 94.3 (19.3) | 116.7 (21.0) | 136.2 (15.1) | 171.5 (26.7) | <.001 |
 ∆TC (n = 3842) |  | 8.7 (28.7) | 1.0 (26.9) | −2.0 (29.4) | −21.9 (39.6) | <.001 |
 ∆LDL-C (n = 3842) |  | 3.8 (24.2) | −0.7 (24.2) | −2.8 (28.0) | −18.3 (34.2) | <.001 |
 ∆Triglycerides (n = 3817) |  | 2.8 (64.7) | −2.2 (75.3) | −1.2 (84.0) | −10.5 (86.1) | 0.002 |
 ∆Non-HDL-C (n = 3842) |  | 7.7 (26.3) | 4.0 (25.3) | 2.3 (29.0) | −15 (37.6) | <.001 |